APOE and synucleinopathy: Since APOE4 also increases the risk for dementia in pure synucleinopathies and specifically exacerbates α-synuclein pathology [59, 60], we propose the disruption of lysosomal metabolism of glycosphingolipids as a common contributing factor in both forms of dementia.